SEC Form 4 · accession 0001209191-15-055752
AMICUS THERAPEUTICS, INC. · FOLD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bradley L Campbell
Officer — Chief Operating Officer
Period of report
Jun 19, 2015
Accepted (ET)
Jun 23, 2015 · 8:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178879
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF2 | Jun 19, 2015 | M | 12,583 | $13.2634 | A | 169,158 | D | |
| Common stockF2 | Jun 19, 2015 | M | 417 | $13.2634 | A | 169,575 | D | |
| Common stockF3 | Jun 19, 2015 | S | 13,000 | $13.2634 | D | 156,575 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy) | $4.16 | Jun 19, 2015 | M | 12,583 | D | Nov 1, 2013 | Nov 16, 2019 | Common Stock | 12,583 | 12,584 | D |
| Stocl Options (right to buy) | $2.81 | Jun 19, 2015 | M | 416 | D | Jun 1, 2014 | Jun 15, 2020 | Common stock | 416 | 19,167 | D |
Explanation of responses
- F1The exercise of stock options and subsequent sales of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2014.
- F2This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.16 to $13.33. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- F3This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.16 to $13.33. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.